Oxetanes
eMolecules 114012-41-8 | Oxetane-3-carboxylic acid | Ambeed | MFCD08669505 | 102.089 | C4H6O3 | 95.000 | OC(=O)C1COC1 | 250mg | 490551547
Oxetane-3-carboxylic acid | Ambeed | 114012-41-8 | MFCD08669505 | 102.089 | C4H6O3 | 95.000 | OC(=O)C1COC1 | 250mg | 490551547
eMolecules 864373-47-7 | Oxetane-2-carboxylic acid | Combi-Blocks | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 1g | 439371455
Oxetane-2-carboxylic acid | Combi-Blocks | 864373-47-7 | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 1g | 439371455
eMolecules 39267-79-3 | 3-Bromooxetane | Accela ChemBio | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 1g | 784390702
3-Bromooxetane | Accela ChemBio | 39267-79-3 | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 1g | 784390702
Chemscene ChemScene | 1-(3-Oxetanyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 250MG | CS-0030593 | 0.97 | 1339890-99-1| MFCD21337762 | 250.11
ChemScene | 1-(3-Oxetanyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 250MG | CS-0030593 | 0.97 | 1339890-99-1| MFCD21337762 | 250.11
eMolecules 1305207-52-6 | Oxetane-3-carbaldehyde | Combi-Blocks | MFCD21604173 | 86.090 | C4H6O2 | 96.000 | O=CC1COC1 | 250mg | 401043987
Oxetane-3-carbaldehyde | Combi-Blocks | 1305207-52-6 | MFCD21604173 | 86.090 | C4H6O2 | 96.000 | O=CC1COC1 | 250mg | 401043987
eMolecules 21635-88-1 | oxetan-3-amine | Pharmablock | MFCD08544363 | 73.095 | C3H7NO | 97 | NC1COC1 | 1g | 551185089
Medchem Express | PPA | 25mg | 781212834 | HY-141664 | 452072-22-9 | MFCD21332845 | 243.340 | C10H13NO2S2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool<|a>
eMolecules 39267-79-3 | 3-Bromooxetane | Advanced ChemBlocks | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 25g | 199465776
3-Bromooxetane | Advanced ChemBlocks | 39267-79-3 | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 25g | 199465776
eMolecules 26272-85-5 | 3-iodooxetane | Pharmablock | MFCD08544403 | 183.976 | C3H5IO | 97.000 | IC1COC1 | 10g | 551186268
3-iodooxetane | Pharmablock | 26272-85-5 | MFCD08544403 | 183.976 | C3H5IO | 97.000 | IC1COC1 | 10g | 551186268
eMolecules 26272-85-5 | 3-IODOOXETANE | AstaTech | MFCD08544403 | 183.976 | C3H5IO | 95.000 | IC1COC1 | 1g | 206681646
3-IODOOXETANE | AstaTech | 26272-85-5 | MFCD08544403 | 183.976 | C3H5IO | 95.000 | IC1COC1 | 1g | 206681646
Medchemexpress LLC RBN-3143 | 2360853-16-1 | C22H28FN3O4S | 50 MG
RBN-3143 is a potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM. It inhibits PARP14-mediated ADP-ribosylation and stabilizes PARP14 in cell lines. RBN-3143 can be used in research of lung inflammation and has been shown to improve steroid-resistant asthma mouse models.
- Potent and NAD+-competitive catalytic PARP14 inhibitor with an IC50 value of 4 nM
- Inhibits PARP14-mediated ADP-ribosylation
- Stabilizes PARP14 in cell lines
- Can be used in research of lung inflammation
- Improves steroid-resistant asthma mouse models
eMolecules 39267-79-3 | 3-bromooxetane | Pharmablock (USA) Inc | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 250g | 254797229
3-bromooxetane | Pharmablock (USA) Inc | 39267-79-3 | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 250g | 254797229
eMolecules 26272-85-5 | 3-Iodooxetane | Oakwood Chemicals | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 25g | 480164358
3-Iodooxetane | Oakwood Chemicals | 26272-85-5 | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 25g | 480164358
eMolecules 1305207-52-6 | Oxetane-3-carbaldehyde | ChemScene | MFCD21604173 | 86.090 | C4H6O2 | 95.000 | O=CC1COC1 | 25g | 441663523
Oxetane-3-carbaldehyde | ChemScene | 1305207-52-6 | MFCD21604173 | 86.090 | C4H6O2 | 95.000 | O=CC1COC1 | 25g | 441663523
Medchemexpress LLC AKR1C1-IN-1 | 4906-68-7 | 99.4% | 293.11 | 10 MG
AKR1C1-IN-1 is a potent and selective inhibitor of human 20α-hydroxysteroid dehydrogenase (AKR1C1), demonstrating a a Ki value of 4 nM for AKR1C1. It is intended for research use only.
- Ki value for AKR1C1: 4 nM
- Inhibition of AKR1C2: 87 nM
- Inhibition of AKR1C3: 4.2 μM
- Inhibition of AKR1C4: 18.2 μM
- Potently inhibits the metabolism of progesterone in AKR1C1-overexpressed BAECs, with an IC50 of 460 nM.
- Target: Aldose Reductase
- Pathway: Metabolic Enzyme/Protease
eMolecules 26272-85-5 | 3-Iodooxetane | Oakwood Chemicals | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 1g | 480164356
3-Iodooxetane | Oakwood Chemicals | 26272-85-5 | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 1g | 480164356